Cancer research has come out ahead of other specialities in the latest round of NHMRC funding announcements, winning $87 million out of almost $400m in investigator grants for 2020.
Other areas of research awarded sizeable levels of funding in NHMRC and Medical Research Future Fund (MRFF) grants include infectious diseases ($84.7 million, cardiovascular disease ($46.5 million), mental health ($54.0 million) and indigenous ($19.4 million).
The funding for cancer research includes projects at the QIMR Berghofer Institute of Medical Research into the genetic basis of breast cancer risk.
The University of Melbourne has also announced several successful projects including research by Professor Sarah-Jane Dawson, of the Sir Peter MacCallum Department of Oncology and Peter MacCallum Cancer Centre into the use of circulating tumour DNA (ctDNA) to serially follow patients and individualise treatment decisions in cancer management across several cancer types.
Also at Peter Mac, Professor Mark Dawson will use an NHMRC grant to investigate how to use epigenetic protein regulators to gain insights into the molecular pathogenesis of cancer and deliver novel therapeutic strategies.